Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879970 · ClinicalTrials.gov registry record · Phase 4
Thiazolidinedione Intervention With Vitamin D Evaluation
A Phase 4 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 4
- Development phase
- 1,332
- Enrollment target
NCT00879970 is a Phase 4 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 1,332 participants.
The verdict
NCT00879970, a Phase 4 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 1,332 participants
- Enrollment target
Study Summary
This study will answer two separate questions. The first question is to test the cardiovascular effects of long-term treatment with rosiglitazone or pioglitazone when used as part of standard of care compared to similar standard of care without rosiglitazone or pioglitazone in patients with type 2 diabetes who have a history of or are at risk for cardiovascular disease. The second question will compare the effects of long-term supplementation of vitamin D on death and cancer
Interventions
- DIETARY_SUPPLEMENT Placebo
- DRUG placebo
- DIETARY_SUPPLEMENT Vitamin D
- DRUG pioglitazone
- DRUG rosiglitazone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,332 participants |
| Start Date | 2009-05 |
| Est. Completion | 2010-11 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00879970
The ClinicalTrials.gov registry entry for NCT00879970 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 1,332 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Placebo is the first listed.
NCT00879970 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00879970 about?
NCT00879970 is a clinical study titled "Thiazolidinedione Intervention With Vitamin D Evaluation". This study will answer two separate questions. The first question is to test the cardiovascular effects of long-term treatment with rosiglitazone or pioglitazone when used as part of standard of care compared to similar standard of care without rosiglitazone or pioglitazone in patients with type 2 ...
What is the current status of trial NCT00879970?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 1,332 participants. The study started on 2009-05. Estimated completion is 2010-11.
What interventions are being tested in trial NCT00879970?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), placebo (DRUG), Vitamin D (DIETARY_SUPPLEMENT), pioglitazone (DRUG), rosiglitazone (DRUG).
Who is sponsoring clinical trial NCT00879970?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.